Spero Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-85.9M | $-86.0M | $157.0K | $4.9M |
| FY2021 | $-64.3M | $-64.3M | — | $9.4M |
| FY2022 | $-7.7M | $-7.7M | — | $9.1M |
| FY2023 | $-33.0M | $-33.0M | — | $7.9M |
| FY2024 | $-23.4M | $-23.4M | — | $7.8M |